Whole body thermochemotherapy in an infant with rhabdomyosarcoma and pulmonary metastases
P. Schippel MD
Department of Anesthesiology, Leipzig University Medical Center, Germany
Search for more papers by this authorI. Lotz MD
Department of Diagnostic Radiology, Leipzig University Medical Center, Germany
Search for more papers by this authorK. Rothe MD
Department of Pediatric Surgery, Leipzig University Medical Center, Germany
Search for more papers by this authorC. Greiner MD
Department of Pediatrics, St. Georg Medical Center, Leipzig, Germany
Search for more papers by this authorCorresponding Author
C. Mauz-Körholz MD
Division of Pediatric Hematology-Oncology and Hemostaseology, Department of Pediatrics, Leipzig University Medical Center, Germany
Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Leipzig Medical Center, Oststr. 21-25, D-04317 Leipzig, Germany.Search for more papers by this authorP. Schippel MD
Department of Anesthesiology, Leipzig University Medical Center, Germany
Search for more papers by this authorI. Lotz MD
Department of Diagnostic Radiology, Leipzig University Medical Center, Germany
Search for more papers by this authorK. Rothe MD
Department of Pediatric Surgery, Leipzig University Medical Center, Germany
Search for more papers by this authorC. Greiner MD
Department of Pediatrics, St. Georg Medical Center, Leipzig, Germany
Search for more papers by this authorCorresponding Author
C. Mauz-Körholz MD
Division of Pediatric Hematology-Oncology and Hemostaseology, Department of Pediatrics, Leipzig University Medical Center, Germany
Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Leipzig Medical Center, Oststr. 21-25, D-04317 Leipzig, Germany.Search for more papers by this author
REFERENCES
- 1 Robins HI, Cohen JD, Schmitt CL, et al. Phase I clinical trial of carboplatin and 41.8°C whole-body hyperthermia in cancer patients. J Clin Oncol 1993; 11: 1787–1794.
- 2 Wiedemann GJ, d'Oleire F, Knop E, et al. Ifosfamide and carboplatin combined with 41.8°C whole-body hyperthermia in patients with refractory sarcoma and malignant teratoma. Cancer Res 1994; 54: 5346–5350.
- 3 Willnow U, Lindner H, Brock D, et al. Treatment of otherwise incurable tumor diseases in childhood using whole body hyperthermia and chemotherapy. Dtsch Med Wschr 1989; 114: 208–213.
- 4 Döll C, Wulff B, van Heek-Romanowski R, et al. Ganzkörperhyperthermie und Chemotherapie bei Kindern mit refraktären malignen Erkrankungen. Kinder-und Jugendmedizin 2001; 1: A13.
- 5 CWS-96-Protokoll in der Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH).
- 6 Mauz-Körholz C, Dietzsch S, Banning U, et al. Heat- and 4-hydroperoxy-ifosfamide-induced apoptosis in B cell precursor leukemias. Int J Hyperthermia 2003; 19: 444–460.
- 7 Mauz-Körholz C, Dietzsch S, Banning U, et al. Mechanisms of hyperthermia- and 4-hydroperoxy-ifosfamide-induced cytotoxicity in T cell leukemia. Anticancer Res 2002; 22: 4243–4248.
- 8 Motzer RJ, Niedzwiecki D, Isaacs M, et al. Carboplatin-based chemotherapy with pharmokokinetic analysis for patients with hemodialysis-dependent renal insufficiency. Cancer Chemother Pharmacol 1990; 27: 234–238.
